levetiracetam 100 MG/ML Oral Solution

What the CMS Formulary Data Shows for levetiracetam 100 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, levetiracetam 100 MG/ML Oral Solution (RxNorm concept RXCUI 403884, generic name levetiracetam) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.

Real-world access to levetiracetam 100 MG/ML Oral Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 766,583 Part D beneficiaries filled levetiracetam 100 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $171,482,383 and an average per-beneficiary annual cost of $223.70. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levetiracetam 100 MG/ML Oral Solution today.